Showing results (11-20 of 279) with videos related to
Sort By:
Pageof 28
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 6, 1998
Mechanisms of antineoplastic action of somatostatin analogsM N Pollak, A V SchallyBiochemical and Biophysical Research Communications|January 14, 1994
Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferationS E Pratt, M N PollakClinical Orthopaedics and Related Research|August 1, 1996
Assessment of pelvic ring stability after injury. Indications for surgical stabilizationS A Olson, A N PollakCancer Research|November 1, 1993
Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned mediaS E Pratt, M N PollakInjury|January 17, 2015
Special topic: Ipsilateral femoral neck and shaft fractures--does evidence give us the answer?Christina L Boulton, Andrew N PollakCancer Prevention Research (Philadelphia, Pa.)|April 1, 2026
Appetite, Obesity, Metabolism, and Malignancy: Do Incretin-Mimetic Drugs Reduce Cancer Risk?Andrew G Renehan, Michael N PollakThe Journal of the American Academy of Orthopaedic Surgeons|September 28, 2006
Timing of wound coverage in extremity war injuriesRandy Sherman, Shahrad Rahban, Andrew N PollakThe Journal of Urology|December 3, 2014
The use of aspirin and the risk of mortality in patients with prostate cancerJonathan Assayag, Michael N Pollak, Laurent AzoulayNPJ Precision Oncology|October 3, 2024
Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expressionChristopher Godina, Michael N Pollak, Helena JernströmJournal of the National Cancer Institute|February 21, 1990
Insulinlike growth factor I: a potent mitogen for human osteogenic sarcomaM N Pollak, C Polychronakos, M RichardPageof 28